PCORI is funding comparative clinical effectiveness research across the cancer care continuum, designed to generate actionable evidence for patients, caregivers, clinicians, and health systems. This funding opportunity emphasizes partnering research and community organizations to run studies with real-world impact.
Eligibility Criteria:
- Proposed project must fit the Cancer Partner PFA focus: comparative clinical effectiveness research across the cancer care continuum.
- Applicants must follow the requirements and submission steps in the PCORI funding announcement (LOI required).
Proposed budget must stay within the maximum direct-cost and indirect-cost limits stated in the PFA.
Funding Details:
- Total funds available: up to USD 60,000,000 (PCORI expects ~4–10 funded projects).
- Max direct costs per project: USD 12,000,000.
- Indirect costs: up to 5%.
- Project duration: up to 5 years.
- Expected funding start date: September 2026.
Deadline:
- Letter of Intent (LOI): January 6, 2026 (5:00 pm ET).
- Full application: May 5, 2026 (5:00 pm ET).
Where to go for further information: